Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2002-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1136/jnnp.72.1.106PMID 11784835PMCID PMC1737716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical symptoms and regional cerebral blood flow in schizophrenia

  2005cited by this paper
• New insights into prefrontal function in schizophrenia

  2001cited by this paper
• Receptor Occupancy by Antipsychotics — Concepts and Findings

  2000cited by this paper
• Neurotransmitter Receptors in Actions of Antipsychotic Medications

  2000cited by this paper
• Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus

  2000cited by this paper
• Quantitative comparison of three- and two-dimensional PET with human brain studies.

  1998cited by this paper
• Effect of a haloperidol challenge on regional brain metabolism in neuroleptic-responsive and nonresponsive schizophrenic patients.

  1998cited by this paper
• Prefrontal cortex activity in people with schizophrenia and control subjects

  1998cited by this paper
• The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task.

  1997cited by this paper
• Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naïve patients.

  1997cited by this paper
• Regional cerebral blood flow changes associated with risperidone treatment in elderly schizophrenia patients: a pilot study.

  1996cited by this paper
• Olanzapine versus Placebo and Haloperidol

  1996cited by this paper
• Detecting activations in PET and fMRI: levels of inference and power.

  1996cited by this paper
• Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol.

  1996cited by this paper
• Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.

  1996cited by this paper
• Antipsychotic drug-induced dysphoria

  1996cited by this paper
• Antipsychotic Drug-Induced Dysphoria

  1995cited by this paper
• Symptoms of Schizophrenia: Methods, Meanings, and Mechanisms

  1995cited by this paper
• A functional neuroanatomy of hallucinations in schizophrenia

  1995cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.

  1994cited by this paper
• Clozapine effects on glucose metabolic rate in striatum and frontal cortex.

  1994cited by this paper
• Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients.

  1993cited by this paper
• Increased blood flow in Broca's area during auditory hallucinations in schizophrenia.

  1993cited by this paper
• Single-photon emission computed tomography with 99mTc-exametazime in unmediated schizophrenic patients

  1993cited by this paper
• Striatal metabolic rate and clinical response to neuroleptics in schizophrenia.

  1992cited by this paper
• Patterns of Cerebral Blood Flow in Schizophrenia

  1992cited by this paper
• PET STUDIES OF DRUG INTERACTION WITH BRAIN REGIONAL GLUCOSE METABOLISM

  1992cited by this paper
• Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia.

  1992cited by this paper
• Regional brain function in hallucinations: a study of regional cerebral blood flow with 99m-Tc-HMPAO-SPECT in patients with auditory hallucinations, tactile hallucinations, and normal controls.

  1989cited by this paper
• The Symptoms of Chronic Schizophrenia

  1987cited by this paper
• Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients.

  1987cited by this paper
• Tomographic measurement of local cerebral glucose metabolic rate in humans with (F‐18)2‐fluoro‐2‐deoxy‐D‐glucose: Validation of method

  1979cited by this paper
• Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

  1978cited by this paper
• A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS

  1970cited by this paper

• Altered Behavior and Neuronal Activity with Paternal Snord116 Deletion

  2025influential citation
• Glycolytic and Krebs cycle enzymes activity in rat prefrontal cortex, hippocampus, and striatum after single and repeated NMDA inhibition by MK-801.

  2022cites this paper
• Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia

  2021cites this paper
• Neuroimaging and Antipsychotics

  2019cites this paper
• Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication

  2018cites this paper
• The effects of olanzapine treatment on brain regional glucose metabolism in neuroleptic‐naive first‐episode schizophrenic patients

  2016cites this paper
• Approaches to Capture Variance Differences in Rest fMRI Networks in the Spatial Geometric Features: Application to Schizophrenia

  2016cites this paper
• Neurocircuits commonly involved in psychiatric disorders and their stimulation and lesion therapies

  2016cites this paper
• Intrinsic Inter-Subject Variability in Functional Neuroimaging: Verification Using Blind Source Separation Features

  2016cites this paper
• Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia.

  2015cites this paper
• “Hyperfrontality” as Seen on FDG PET in Unmedicated Schizophrenia Patients With Positive Symptoms

  2014cites this paper
• Limbic activity in antipsychotic naïve first-episode psychotic subjects during facial emotion discrimination

  2014cites this paper
• Acute effects of single‐dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain

  2013cites this paper
• Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics

  2012cites this paper
• Prefrontal networks in schizophrenia

  2012cites this paper
• Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET

  2012cites this paper
• Antipsychotic medication and prefrontal cortex activation: a review of neuroimaging findings.

  2012influential citation
• Resting State Blood Flow and Glucose Metabolism in Psychiatric Disorders

  2012cites this paper
• The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory

  2012cites this paper
• Prefrontal networks in schizophrenia: insights from neuroimaging

  2012cites this paper
• Functional magnetic resonance imaging and treatment strategies in schizophrenia.

  2012cites this paper
• Mood Related Insights

  2011cites this paper
• Mapping Prodromal Psychosis

  2011cites this paper
• Antipsychotic dose and diminished neural modulation: a multi-site fMRI study.

  2011cites this paper
• Probing brain function with pharmacological MRI

  2011cites this paper
• Functional and pharmacological MRI in understanding brain function at a systems level.

  2011cites this paper
• INTERNATIONAL HEALTH NEWS

  2010cites this paper
• Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit

  2010cites this paper
• Short-term effects of antipsychotic treatment on cerebral function in drug-naive first-episode schizophrenia revealed by "resting state" functional magnetic resonance imaging.

  2010cites this paper
• Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry.

  2010cites this paper
• Abnormal anterior cingulum integrity in first episode, early-onset schizophrenia: a diffusion tensor imaging study.

  2010cites this paper
• Uso della PET e della SPECT in Psichiatria

  2010cites this paper
• An fMRI study of visual attention and sensorimotor function before and after antipsychotic treatment in first-episode schizophrenia.

  2009cites this paper
• The audacity of proteomics: a chance to overcome current challenges in schizophrenia research

  2009cites this paper
• Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia

  2009cites this paper
• Topographic analysis of individual activation patterns in medial frontal cortex in schizophrenia

  2009influential citation
• Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.

  2008cites this paper
• Taq1A polymorphism in the dopamine D2 receptor gene predicts brain metabolic response to aripiprazole in healthy male volunteers

  2008cites this paper
• Neuroimaging studies of the early stages of psychosis: A critical review

  2008cites this paper
• FDG-PET in never-previously medicated psychotic adolescents treated with olanzapine or haloperidol.

  2007cites this paper
• Patterns of anterior cingulate activation in schizophrenia: a selective review

  2007cites this paper
• The effects of antipsychotic treatment on cerebral structure and function in schizophrenia

  2007cites this paper
• Effects of acute antipsychotic treatment on brain activation in first episode psychosis: an fMRI study.

  2007cites this paper
• Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia.

  2007cites this paper
• Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex.

  2007cites this paper
• Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.

  2007cites this paper
• The dopamine system and the pathophysiology of schizophrenia: a basic science perspective.

  2007cites this paper
• Ketamine dose-dependently induces high-frequency oscillations in the nucleus accumbens in freely moving rats.

  2006cites this paper
• Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia.

  2005cites this paper
• Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia.

  2005cites this paper
• Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients

  2005cites this paper
• Risperidone: a review

  2005cites this paper
• Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia

  2004cites this paper
• Effect of acute antipsychotic administration on dopamine synthesis in rodents and human subjects using 6‐[18F]‐L‐m‐tyrosine

  2004cites this paper
• Immediate effects of risperidone on cerebral activity in healthy subjects: a comparison with subjects with first-episode schizophrenia.

  2004influential citation
• A functional magnetic resonance imaging study of cortical asymmetry in bipolar disorder.

  2004cites this paper
• Cerebral metabolic patterns in chronic and recent-onset schizophrenia.

  2003cites this paper
• Amphetamine sensitization of hallucinatory-like behaviors is dependent on prefrontal cortex in nonhuman primates.

  2003cites this paper
• Tc-99 HMPAO SPECT study of regional cerebral blood flow in olanzapine-treated schizophrenic patients

  2003cites this paper
• SPECT imaging, clinical features, and cognition before and after low doses of amisulpride in schizophrenic patients with the deficit syndrome.

  2002cites this paper
• Does risperidone act better in schizophrenic patients who have a family or obstetric history?

  2002cites this paper
• Current awareness in human psychopharmacology.

  2002cites this paper
• Current awareness in human psychopharmacology

  2002cites this paper
• Basal ganglia structure and the effects of neuroleptic treatment in schizophrenia

  2002cites this paper
• [PET in neurology and psychiatry I. PET with FDG in the study of the CNS].

  2002cites this paper
• PET en neurología y psiquiatría I. PET con FDG en el estudio del SNC

  2002cites this paper